Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis

[1]  E. Siew,et al.  Biological markers of acute kidney injury. , 2011, Journal of the American Society of Nephrology : JASN.

[2]  E. Giovannucci,et al.  Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill* , 2011, Critical care medicine.

[3]  J. Neilson,et al.  Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008 , 2011, BJOG : an international journal of obstetrics and gynaecology.

[4]  M. Boyle,et al.  Pharmacological versus non-pharmacological antipyretic treatments in febrile critically ill adult patients: a systematic review and meta-analysis. , 2011, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

[5]  R. Bellomo,et al.  Urinary hepcidin: an inverse biomarker of acute kidney injury after cardiopulmonary bypass? , 2010, Current opinion in critical care.

[6]  A. Maisel,et al.  Evolving use of biomarkers for kidney injury in acute care settings , 2010, Current opinion in critical care.

[7]  M. Perazella,et al.  Acute tubular necrosis and pre-renal acute kidney injury: utility of urine microscopy in their evaluation- a systematic review , 2010, International Urology and Nephrology.

[8]  R. Bellomo,et al.  Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. , 2010, Journal of the American College of Cardiology.

[9]  Alan E. Jones,et al.  Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. , 2010, JAMA.

[10]  M. Singer,et al.  Cardioprotection, attenuated systemic inflammation, and survival benefit of &bgr;1-adrenoceptor blockade in severe sepsis in rats* , 2010, Critical care medicine.

[11]  K. Shah,et al.  Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock , 2010, Journal of Inflammation.

[12]  C. Ronco,et al.  Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population , 2009, Intensive Care Medicine.

[13]  C. Ronco,et al.  Pathogenesis of acute kidney injury during sepsis. , 2009, Current drug targets.

[14]  R. Bellomo,et al.  Septic shock induces distinct changes in sympathetic nerve activity to the heart and kidney in conscious sheep. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[15]  P. Nickerson,et al.  Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  J. Parrillo,et al.  MULTICENTER STUDY OF EARLY LACTATE CLEARANCE AS A DETERMINANT OF SURVIVAL IN PATIENTS WITH PRESUMED SEPSIS , 2008, Shock.

[17]  H. Stelfox,et al.  Occurrence and outcome of fever in critically ill adults* , 2008, Critical care medicine.

[18]  T. Benfield,et al.  Common TNF-α, IL-1β, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis , 2007, BMC infectious diseases.

[19]  J. Siddiqui,et al.  Mechanisms of Mortality in Early and Late Sepsis , 2006, Infection and Immunity.

[20]  M. Moss.  Epidemiology of sepsis: race, sex, and chronic alcohol abuse. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  E. Benveniste,et al.  LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia , 2005 .

[22]  E. Abraham,et al.  Year in review in Critical Care, 2004: sepsis and multi-organ failure , 2005, Critical care.

[23]  J. Yélamos,et al.  Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. , 2005, The American journal of pathology.

[24]  B. Guidet,et al.  Incidence and impact of organ dysfunctions associated with sepsis. , 2005, Chest.

[25]  A. Riedel,et al.  Severe Sepsis in Managed Care: Analysis of Incidence, One-Year Mortality, and Associated Costs of Care , 2004, Journal of managed care pharmacy : JMCP.

[26]  G. Jacobsen,et al.  Early lactate clearance is associated with improved outcome in severe sepsis and septic shock* , 2004, Critical care medicine.

[27]  Mitchell M. Levy,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[28]  P. Carvalho,et al.  [Advances in sepsis diagnosis and treatment]. , 2003, Jornal de pediatria.

[29]  I. Chaudry,et al.  Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity , 2003, Journal of leukocyte biology.

[30]  D. Annane,et al.  Corticosteroids in Sepsis: From Bench to Bedside? , 2003, Shock.

[31]  M. Levy,et al.  Clinical review: Fever in intensive care unit patients , 2003, Critical care.

[32]  R. Kleinpell,et al.  Advances in the understanding of clinical manifestations and therapy of severe sepsis: an update for critical care nurses. , 2003, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[33]  P A Ward,et al.  Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. , 2001, The American journal of pathology.

[34]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[35]  G. Bernard,et al.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. , 1997, The New England journal of medicine.

[36]  F. Shann.  Antipyretics in severe sepsis , 1995, The Lancet.

[37]  P. Mackowiak.  Fever: Blessing or Curse? A Unifying Hypothesis , 1994, Annals of Internal Medicine.

[38]  R. Bone.  Guidelines for the Use of Innovative Therapies in Sepsis , 1993 .

[39]  E. Mellits,et al.  Acetaminophen: more harm than good for chickenpox? , 1989, The Journal of pediatrics.

[40]  G. Jackson,et al.  Increased virus shedding with aspirin treatment of rhinovirus infection. , 1975, JAMA.

[41]  P. Hench,et al.  FEVER THERAPY: RESULTS FOR GONORRHEAL ARTHRITIS, CHRONIC INFECTIOUS (ATROPHIC) ARTHRITIS, AND OTHER FORMS OF RHEUMATISM , 1935 .

[42]  R. Bellomo,et al.  Pathophysiology of septic acute kidney injury: a different view of tubular injury. , 2010, Contributions to nephrology.

[43]  G. Robledo,et al.  Cortistatin, a new antiinfl ammatory peptide with therapeutic eff ect on lethal endotoxemia , 2006 .

[44]  I. Chaudry,et al.  The Apoptotic Response of the Lymphoid Immune System to Trauma, Shock, and Sepsis , 2000 .